COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Saved in:
Main Authors: | Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Idanna Innocenti, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Blood Advances |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952924006281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience
by: Idanna Innocenti, et al.
Published: (2024-12-01) -
Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
by: Waqas Jehangir, et al.
Published: (2020-01-01) -
Forecasting the COVID-19 Diffusion in Italy and the Related Occupancy of Intensive Care Units
by: Livio Fenga
Published: (2021-01-01) -
Bootstrap Order Determination for ARMA Models: A Comparison between Different Model Selection Criteria
by: Livio Fenga
Published: (2017-01-01) -
The Representation of Landscape through Drawings and Utopian Visions
by: Livio Sacchi
Published: (2024-12-01)